Astrocyte reactivity with late-onset cognitive impairment assessed in vivo using 11C-BU99008 PET and its relationship with amyloid load
Year: 2021
Type: article
Study design: Observational Study
Abstract: 11 C-BU99008 is a novel positron emission tomography (PET) tracer that enables selective imaging of astrocyte reactivity in vivo. To explore astrocyte reactivity associated with Alzheimer’s disease, 11 older, cognitively impaired (CI) subjects and 9 age-matched healthy controls (HC) underwent 3T magnetic resonance imaging (MRI), 18 F-florbetaben and 11 C-BU99008 PET. The 8 amyloid (Aβ)-positive CI subjects had higher 11 C-BU99008 uptake relative to HC across the whole brain, but particularly in frontal, temporal, medial temporal and occipital lobes. Biological parametric mapping demonstrated a positive voxel-wise neuroanatomical correlation between 11 C-BU99008 and 18 F-florbetaben. Autoradiography using 3 H-BU99008 with post-mortem Alzheimer’s brains confirmed through visual assessment that increased 3 H-BU99008 binding localised with the astrocyte protein glial fibrillary acid protein and was not displaced by PiB or florbetaben. This proof-of-concept study provides direct evidence that 11 C-BU99008 can measure in vivo astrocyte reactivity in people with late-life cognitive impairment and Alzheimer’s disease. Our results confirm that increased astrocyte reactivity is found particularly in cortical regions with high Aβ load. Future studies now can explore how clinical expression of disease varies with astrocyte reactivity.
Source: Molecular Psychiatry
Authors: Valeria Calsolaro, Paul M. Matthews, Cornelius K. Donat, Nicholas R. Livingston, Grazia D. Femminella, Sandra Silva Guedes, Jim Myers, Zhen Fan, Robin J. Tyacke, Ashwin V. Venkataraman, Robert Perneczky, Roger Gunn, Eugenii A. Rabiner, Steve Gentleman, Christine A. Parker, Philip S. Murphy, Paul B. Wren, Rainer Hinz, Magdalena Sastre, David J. Nutt, Paul Edison
Institutions: Imperial College London, UK Dementia Research Institute, German Center for Neurodegenerative Diseases, Munich Cluster for Systems Neurology, Ludwig-Maximilians-Universität München, Invicro (United Kingdom), King's College London, GlaxoSmithKline (United Kingdom), University of Manchester, Cardiff University
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $4,480
Funders: GlaxoSmithKline, Alzheimer's Society, National Institute for Health and Care Research, Imperial College London, Imperial College Healthcare NHS Trust, Novo Nordisk, UK Dementia Research Institute, Dementias Platform UK, National Institutes of Health, Medical Research Council, NIHR Imperial Biomedical Research Centre
Awards: NIHR Senior Investigator Award, Capital award for UK DRI at Imperial College London, UKDP: Integrated DEmentiA research environment (IDEA), Pathfinder: An experimental medicine study of the 18 kD translocator protein as a novel neuroimmunodulatory target for multiple sclerosis, NIHR Senior Investigator Award, MICA: Dementias Platform UK 2 - Integrated Dementia Experimental Medicine, Consortium Building
OpenAlex ID: W3181451168
